Type IV-A3 CRISPR-Cas systems drive inter-plasmid conflicts by acquiring spacers in trans
F. Benz, S. Camara-Wilpert, J. Russel, K. G. Wandera, R. Cepaite, M. Ares-Arroyo, J. V. Gomes-Filho, F. Englert, J. Kuehn, S. Gloor, A. Cuenod, M. Aguila-Sans, L. Maccario, A. Egli, L. Randau, P. Pausch, E. Rocha, C. L. Beisel, J. S. Madsen, D. Bikard, A. R. Hall, S. J. Soerensen, R. Pinilla-Redondo
Abstract
Type IV-A CRISPR-Cas systems are primarily encoded on plasmids and form multi-subunit ribonucleoprotein complexes with unknown biological functions. In contrast to other CRISPR-Cas types, they lack the archetypical CRISPR acquisition module and encode a DinG helicase instead of a nuclease component. Type IV-A3 systems are carried by large conjugative plasmids that often harbor multiple antibiotic-resistance genes. Although their CRISPR array contents suggest a role in inter-plasmid conflicts, this function and the underlying mechanisms have remained unexplored. Here, we demonstrate that a plasmid-encoded type IV-A3 CRISPR-Cas system co-opts the type I-E adaptation machinery from its clinical Klebsiella pneumoniae host to update its CRISPR array. Furthermore, we demonstrate that robust interference of conjugative plasmids and phages is elicited through CRISPR RNA-dependent transcriptional repression. By targeting plasmid core functions, type IV-A3 can prevent the uptake of incoming plasmids, limit their horizontal transfer, and destabilize co-residing plasmids, altogether supporting type IV-A3s involvement in plasmid competition. Collectively, our findings shed light on the molecular mechanisms and ecological function of type IV-A3 systems and have broad implications for understanding and countering the spread of antibiotic resistance in clinically relevant strains.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Type IV CRISPR-Cas systems are highly diverse and involved in competition between plasmids
R. Pinilla-Redondo, D. Mayo-Munoz, … S. A. Shah·bioRxiv·Sep 24, 2019
- Identification of a Type IV CRISPR-Cas system located exclusively on IncHI1B/ IncFIB plasmids in Enterobacteriaceae
E. Newire, A. Aydin, … A. Roberts·bioRxiv·Jan 31, 2019
- Interference Requirements of Type III CRISPR-Cas Systems from Thermus thermophilus
K. Karneyeva, M. Kolesnik, … K. Severinov·bioRxiv·Sep 3, 2023
- CRISPR-Cas is beneficial in plasmid competition, but limited by competitor toxin-antitoxin activity when horizontally transferred
David Sünderhauf, Jahn R Ringger, … Stineke van Houte·PLoS BiologyPeer-reviewed·Feb 19, 2026
- Mobile element warfare via CRISPR and anti-CRISPR in Pseudomonas aeruginosa
L. M. Leon, A. E. Park, … J. Bondy-Denomy·Nucleic Acids ResearchPeer-reviewed·Feb 5, 2021
- Visualization of Type IV-A1 CRISPR-mediated repression of gene expression and plasmid replication
Mariana Sanchez-Londono, Selina Rust, … Lennart Randau·Nucleic Acids ResearchPeer-reviewed·Sep 24, 2024